Afuco™ Anti-CSF1 ADCC Recombinant Antibody (Lacnotuzumab), ADCC Enhanced (CAT#: AFC-TAB-029ML)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CSF1. Lacnotuzumab is a human monoclonal antibody that can be potentially used in the treatment of Cancers, breast, Pigmented villonodular synovitis (PVNS), Tenosynovitis.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location
RNA Expression

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Humanized
  • Type
  • ADCC enhanced antibody
  • Specificity
  • Human CSF1
  • Species Reactivity
  • Human
  • Clone
  • Lacnotuzumab
  • Applications
  • ELISA, IHC, FC, IP, IF, FuncS
  • Conjugate
  • Unconjugated
  • Generic Name
  • Lacnotuzumab
  • Related Disease
  • Cancers, breast, Pigmented villonodular synovitis (PVNS), Tenosynovitis

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • Colony stimulating factor 1; "colony stimulating factor 1 macrophage"; M-CSF; macrophage colony stimulating factor 1; MCSF; MGC31930

Related Resources

  • Biosimilar Overview
  • Related Signaling Pathways
Please refer to Lacnotuzumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Lacnotuzumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Lacnotuzumab"

Anti-Human CSF1 Recombinant Antibody (Lacnotuzumab)
Recombinant monoclonal antibody to CSF1. Lacnotuzumab is a human monoclonal antibody that can be potentially used in the treatment of Cancers, breast, Pigmented villonodular synovitis (PVNS), Tenosynovitis.

See other products for "Clone Lacnotuzumab"

See other products for "CSF1"

Human Antibody

CAT Product Name Application Type
TAB-187CL Human Anti-CSF1 Recombinant Antibody (TAB-187CL) ELISA Human IgG

Blocking Antibody

CAT Product Name Application Type
NEUT-504CQ Rat Anti-Csf1 Recombinant Antibody (clone 5A1) Block Rat IgG1

Rabbit Monoclonal Antibody

CAT Product Name Application Type
MOR-0824 Hi-Affi™ Rabbit Anti-CSF1 Recombinant Antibody (clone DS824AB) ICC, IHC-P, IP, WB Rabbit IgG

Humanized Antibody

CAT Product Name Application Type
TAB-029ML Anti-Human CSF1 Recombinant Antibody (Lacnotuzumab) ELISA, IHC, FC, IP, IF, FuncS IgG1, κ

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for AFC-TAB-029ML. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare